Characterizing hereditary and acquired defects of plasminogen

Area of Science:

• Hematology
• Biochemistry
• Molecular Biology

Background:

• Plasminogen, the precursor to plasmin, plays a crucial role in fibrinolysis.
• Acquired plasminogen defects are frequently associated with elevated fibrinolytic activity.
• Congenital plasminogen defects, presenting with varying protein levels and activation patterns, have been linked to thrombotic events.

Purpose of the Study:

• To elucidate the causes and diagnostic implications of acquired and congenital plasminogen defects.
• To differentiate between various types of plasminogen defects using immunochemical and amidolytic assays.
• To investigate the association between plasminogen defects and thrombotic disease.

Main Methods:

• Immunochemical assays for plasminogen quantification.
• Chromogenic assays measuring plasminogen activity using S2251 substrate.
• Amidolytic measurement of plasmin formation with streptokinase (SK) as an activator.
• Analysis of plasminogen activation patterns.

Main Results:

• Identified acquired plasminogen defects in conditions with increased fibrinolytic activity, including thrombolytic therapy.
• Characterized congenital plasminogen defects with low protein levels or defective activation patterns.
• Associated defective plasminogen activation with thromboembolic disease.
• Described a congenital defect involving decreased synthesis of normal plasminogen, not necessarily linked to thrombosis.

Conclusions:

• Decreased plasminogen levels in assays are diagnostically helpful in acquired hyperfibrinolytic states.
• Congenital plasminogen defects, particularly those with impaired activation, are significant in the context of thrombotic disease.
• Distinguishing between different types of plasminogen defects aids in understanding their clinical relevance.